[Cholesterol and lipid lowering effects and vascular action of p-chlororphenoxy-alpha-isobutyrate of 3-hydroxymethyl-pyridine-hydrochloric acid (clofinol)].
D000818:Animals; D000924:Anticholesteremic Agents; D001011:Aorta / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects*; D002415:Cats; D002645:Chickens; D002784:Cholesterol / Q000097:blood*; D002791:Cholesterol, Dietary; D002994:Clofibrate / Q000494:pharmacology; D004285:Dogs; D004341:Drug Evaluation; D006321:Heart / Q000187:drug effects; D000960:Hypolipidemic Agents; D008055:Lipids / Q000097:blood*; D008099:Liver / Q000187:drug effects; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats
D000924:Anticholesteremic Agents; D002791:Cholesterol, Dietary; D000960:Hypolipidemic Agents; D008055:Lipids; D011725:Pyridines; D002784:Cholesterol; D002994:Clofibrate
Sugli effetti ipocolesterolemizzanti, ipolipidemizzanti e vascolari del p-clorofenossi-alfa-isobutirrato di 3-idrossimetilpiridina cloridrato (clofinolo.